Luisa Tomasello
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
65
Citations
1,069
Est. group size
~3
Recurring co-author estimate
Active years
19
Publishing since 2007
Luisa Tomasello's research focuses on the molecular biology of blood cancers, particularly chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL). Her work examines how small RNA molecules (like microRNAs and tRNA fragments) and specific genes (such as PTPRG and BCR-ABL1) contribute to disease development, drug resistance, and patient outcomes. This research combines laboratory experiments with clinical data analysis to better understand leukemia biology and identify potential treatment targets.
Publication output has fluctuated over the past decade with a notable spike in 2023, following a generally increasing trend from 2017 through 2021.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- PDCD1 (PD-1) is a direct target of miR-15a-5p and miR-16-5p
Signal Transduction and Targeted Therapy · 2022
- Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG
International Journal of Molecular Sciences · 2022
- Successful Preservation of Native BCR::ABL1 in Chronic Myeloid Leukemia Primary Leukocytes Reveals a Reduced Kinase Activity
Frontiers in Oncology · 2022
- Clinicopathological Variables and Outcome in Chronic Myeloid Leukemia Associated With BCR-ABL1 Transcript Type and Body Weight: An Outcome of European LeukemiaNet Project
Cancer Control · 2021
- Successful preservation of BCR‐ABL1 protein and direct measure of kinase activity in peripheral blood of CML and Ph+ ALL patients unveil a kinase inhibitory activity present in CML cells
The FASEB Journal · 2021
- Effect of BCR-ABL1 Transcript Type and Body Weight on Outcome in Chronic Myeloid Leukemia
Blood · 2021
- Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia
International Journal of Molecular Sciences · 2020
- Aberrant DNA methylation of <i>PTPRG</i> as one possible mechanism of its under‐expression in CML patients in the State of Qatar
Molecular Genetics & Genomic Medicine · 2020
- Clinicopathological Variables and Outcome in Chronic Phase Chronic Myeloid Leukemia Associated with BCR-ABL1 Transcript Type and Obesity
Blood · 2020
- Clinicopathological Variables and Outcome in Chronic Phase Chronic Myeloid Leukemia Associated with BCR-ABL1 Transcript Type and Body Weight
Preprints.org · 2020
- Down-regulation of Protein Tyrosine Phosphatase Receptor Gamma (PTPRG) in Chronic Myeloid Leukemia Patients in The State of Qatar is Due to Aberrant DNA Methylation Mechanism
Research Square (Research Square) · 2020
- Dysregulation of different classes of tRNA fragments in chronic lymphocytic leukemia
Proceedings of the National Academy of Sciences · 2019
- Experimental Validation of MicroRNA Targets: Luciferase Reporter Assay
Methods in molecular biology · 2019
- Experimental Validation of MicroRNA Targets: Analysis of MicroRNA Targets Through Western Blotting
Methods in molecular biology · 2019
- Experimental Validation of MicroRNA Targets: Mutagenesis of Binding Regions
Methods in molecular biology · 2019
- Proceedings of the National Academy of Sciences×4
- Blood×4
- Methods in molecular biology×4
- Frontiers in Cell and Developmental Biology×2
- International Journal of Molecular Sciences×2
- Anna Tessari
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- You Li
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jia Shen
Biochemistry, Genetics and Molecular Biology · Indiana University
- Dario Palmieri
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Xiao Wang
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile